Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Prostate. 2014 Jul 7;74(12):1209–1221. doi: 10.1002/pros.22837

Fig. 8.

Fig. 8

Antioxidants inhibit HNK-induced increase in LC3BII protein level. A: Immunoblotting for LC3BII (pointed by arrows) in PC-3 and LNCaP cells after 2 h pretreatment with 4 mM NAC and then 24 h exposure to DMSO or 40 μM HNK in the absence or presence of NAC. B: Immunoblotting for LC3BII (pointed by an arrow) from PC-3 cells after 1 h pretreatment with 100 U/mL of PEG-SOD and then 24 h exposure to DMSO or 40 μM HNK in the absence or presence of PEG-SOD. C: Immunoblotting for LC3BII (pointed by an arrow) in PC-3 cells after 1 h pretreatment with 100 U/mL of PEG-catalase and then 24 h exposure to DMSO or 40 μM HNK in the absence or presence of PEG-catalase. Quantitation relative to DMSO-treated control (first lane) is shown on top of bands.